مباشر

FierceBiotechGilead loosens ties to Arcus after TIGIT dream finally ends in phase 3 failure FierceBiotechWith $50M from Flagship Pioneering, Serif strives to write new chapter for DNA medicines Lonza NewsFDA-backed drug project tests modeling to reduce some human studies - Stock Titan Thermo FisherSaladax Biomedical and Thermo Fisher Scientific Partner on Global Distribution of Drug Monitoring Assays - Clinical Lab Products Thermo FisherTD Cowen Lowers Thermo Fisher (TMO) Price Target, Keeps Buy Rating - Yahoo Finance Lonza NewsLonza Group AG stock (CH0013841017): Is its biopharma contract model resilient enough for new growth - AD HOC NEWS FierceBiotechReplimmune ramps up layoffs to cover 60% of workforce amid ongoing fallout of FDA rejection 10x Genomics Blog10x Genomics debuts Atera, a new platform to redefine how biology is measured and understood at AACR 2026 - SelectScience IlluminaClinical Genomic Market: Growth and Outlook Driven by Illumina, - openPR.com Thermo FisherAssessing Thermo Fisher Scientific (TMO) Valuation After New PCR Launch And Data Partnerships - simplywall.st Curiosis Inc.Working capital per share of Curiosis, Inc. – KRX:494120 - TradingView WatersWaters Corporation Schedules First Quarter 2026 Earnings Conference Call - ChartMill

Cell ٢٥ نوفمبر ٢٠٢٥

ABP1/ABL3-TMK1 cell-surface auxin signaling targets PIN2-mediated auxin fluxes for root gravitropism

Publication date: 30 October 2025Source: Cell, Volume 188, Issue 22Author(s): Lesia Rodriguez, Lukáš Fiedler, Minxia Zou, Caterina Giannini, Aline Monzer, Dmitr...

Publication date: 30 October 2025Source: Cell, Volume 188, Issue 22Author(s): Lesia Rodriguez, Lukáš Fiedler, Minxia Zou, Caterina Giannini, Aline Monzer, Dmitrii Vladimirtsev, Marek Randuch, Yongfan Yu, Zuzana Gelová, Inge Verstraeten, Jakub Hajný, Meng Chen, Shutang Tan, Lukas Hoermayer, Lanxin Li, Maria Mar Marques-Bueno, Zainab Quddoos, Gergely Molnár, Ivan Kulich, Yvon Jaillais